Denver Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Denver Investment Advisors's NVS Position: Q1 2018 in Review
Denver Investment Advisors reduced its Novartis (NVS) stake by 1.7% in Q1 2018, selling an estimated $36.7K and leaving 27,320 shares worth $1.98M. The position accounts for 0.1% of the portfolio, ranked #172.
Denver Investment Advisors first reported a position in NVS in Q2 2013 and has held it in 20 quarters since. The position peaked at $2.49M in Q3 2013. 1,013 funds tracked by Wall St. Rank hold NVS as of Q1 2018.
- Denver Investment Advisors held 27,320 shares of Novartis worth $1.98M as of Q1 2018.
- Denver Investment Advisors sold 482 Novartis shares in Q1 2018, an estimated $36.7K.
- Novartis made up 0.1% of Denver Investment Advisors's portfolio in Q1 2018, its #172 holding.
- Denver Investment Advisors first reported a position in Novartis in Q2 2013 and has held it in 20 quarters since.
- Denver Investment Advisors's Novartis position peaked at $2.49M in Q3 2013.
- 1,013 funds tracked by Wall St. Rank held Novartis as of Q1 2018.
Based on Denver Investment Advisors's 13F filing for Q1 2018, filed 10 May 2018.